Title of Collaborative Activity: |
FDA /Cancer Diagnosis Program (CDP) monthly meeting |
Description of Collaborative Activity: |
Participants discuss proposed integral markers and process for regulatory input into integral markers/assays for clinical trials. |
Type of Collaborative Activity: |
Other
|
Year the Collaborative Activity Originated: |
2010 |
NIH Participating Institutes/Centers/Office of the Director: |
NCI |
HHS Agency Collaborators on this Activity: |
FDA |
